Medexus Pharmaceuticals Inc. (TSE:MDP – Get Free Report) shares hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as C$5.25 and last traded at C$4.91, with a volume of 44910 shares traded. The stock had previously closed at C$5.07.
Medexus Pharmaceuticals Price Performance
The firm has a 50-day simple moving average of C$4.16 and a 200 day simple moving average of C$3.49. The stock has a market capitalization of C$160.52 million, a P/E ratio of -72.43 and a beta of 0.22.
Medexus Pharmaceuticals Company Profile
Medexus is a leading specialty pharmaceutical company with a strong North American commercial platform and a growing portfolio of innovative and rare disease treatment solutions. Medexus’s current focus is on the therapeutic areas of hematology and hematology-oncology and rheumatology and allergy.
See Also
- Five stocks we like better than Medexus Pharmaceuticals
- PriceSmart Stock Eyes $220 as Chile Expansion Fuels Growth
- Dollar Tree’s Turnaround Is Starting to Take Root
- Why Levi’s Digital Strategy Is Paying Off in a Big Way
- Constellation Brands: Beer Growth and Buybacks Mask Stock’s Slump
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
